DiagnaMed Holdings Corp. has taken significant steps to bolster its intellectual property portfolio by partnering with Intellectual Property Ontario (IPON) and the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) IP Assist program. Through these initiatives, DiagnaMed stands to receive up to $150,000 in non-dilutive funding support.
Under the IPON Partner Program, DiagnaMed can access up to $35,000 in initial funding, along with an additional $100,000 grant for intellectual property protection and commercialization services. IPON aims to provide innovators, businesses, and researchers with resources such as IP education, financial support, and mentorship to enhance their capacity for growth and competitiveness in the market.
DiagnaMed has also completed IP Assist Level 1 with the NRC IRAP program, making the company eligible for up to $50,000 in expert IP services. NRC IRAP offers comprehensive advisory services and funding to foster the growth of Canadian small and medium-sized businesses. The IP Assist program specifically focuses on supporting companies in achieving their commercial goals and safeguarding their innovations.
Fabio Chianelli, Chairman and CEO of DiagnaMed, expressed enthusiasm for the increased support: “We have made significant technical and operating progress with CERVAI™, our novel brain health AI solution, and we are pleased to strengthen support of our intellectual property for commercialization with a potential $150,000 non-dilutive funding from IPON and IP Assist programs.”
With this funding, DiagnaMed can further invest in research and development, expanding its intellectual property portfolio through patents, copyrights, trademarks, and trade secrets. These efforts align with the company’s global commercialization plans for CERVAI™, their world-first consumer brain health and wellness AI solution.
CERVAI™ estimates brain age and provides a brain health score, utilizing a Brain Age™ Estimation and Brain Health Assessment tool. By collecting neural activity data with an electroencephalogram (EEG) headset, CERVAI™ can determine if a brain is aging more quickly or slowly than usual for a healthy individual. Additionally, it can assess whether a person has a healthy brain or is in the early stages of cognitive decline.
The non-dilutive funding from IPON and IP Assist will enable DiagnaMed to continue developing CERVAI™ and explore personalized diagnostics and interventions that may help decrease the development or progression of cognitive decline.
FAQ:
Q: What is the IPON Partner Program?
A: The IPON Partner Program is a funding initiative that supports innovators, businesses, and researchers by providing financial support for intellectual property protection and commercialization services.
Q: What is the NRC IRAP IP Assist program?
A: The NRC IRAP IP Assist program is part of the National Research Council of Canada Industrial Research Assistance Program. It offers expert IP services to support small and medium-sized businesses in achieving their commercial goals and safeguarding their innovations.
Q: What is CERVAI™?
A: CERVAI™ is a consumer brain health and wellness AI solution developed by DiagnaMed. It estimates brain age and provides a brain health score using a Brain Age™ Estimation and Brain Health Assessment tool.
Definitions:
1. IPON: Intellectual Property Ontario (IPON) is an organization that provides resources such as IP education, financial support, and mentorship to innovators, businesses, and researchers to enhance their capacity for growth and competitiveness in the market.
2. NRC IRAP: The National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) is a program that offers comprehensive advisory services and funding to foster the growth of Canadian small and medium-sized businesses.
3. IP Assist: IP Assist is a specific program within NRC IRAP that focuses on supporting companies in achieving their commercial goals and safeguarding their innovations through expert IP services.
4. Non-dilutive funding: Non-dilutive funding refers to financial support received by a company that does not require giving up ownership or equity in the company.
Related Links:
– Intellectual Property Ontario
– National Research Council of Canada Industrial Research Assistance Program
The source of the article is from the blog publicsectortravel.org.uk